The efficacy of rituximab in patients with splenectomized refractory chronic ITP

The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura

Semir Pasa1, Abdullah Altintas1, Timucin Cil2, Ramazan Danis3 and Orhan Ayyildiz1
(1) Department of Hematology, Faculty of Medicine, Dicle University, Diyarbakir, 21280, Turkey
(2) Department of Oncology, Faculty of Medicine, Dicle University, Diyarbakir, 21280, Turkey
(3) Department of Nephrology, Faculty of Medicine, Dicle University, Diyarbakir, 21280, Turkey

J Thromb Thrombolysis (2009) 27:329-333

Keywords Refractory chronic idiopathic thrombocytopenic purpura - Splenectomy - Anti-CD20 monoclonal antibody - Rituximab

pozri abstrakt